Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
9 Patents
#110 in South San Francisco, CA
#7,735 in California
#32,588 in US
Gryphon Therapeutics, Inc.
Forward Citations = 160
15 inventors:
South San Francisco, CA, United States of America
Gryphon Therapeutics, Inc.
% Expired Patents = 44.4
Forward Citations = 160
Loading Chart...
Loading Chart...
15 inventors (with patents filed for the assignee):
Stephen B H Kent (5 out of 21 patents)
Reyna J Simon (3 out of 11 patents)
Keith Rose (3 out of 11 patents)
4. Robin E Offord (3 out of 13 patents)
5. Paolo Botti (2 out of 14 patents)
6. James A Bradburne (2 out of 3 patents)
7. Lynne Canne (2 out of 3 patents)
8. Jill Wilken (2 out of 3 patents)
9. Christie L Hunter (1 out of 7 patents)
10. Shiah-yun Chen (1 out of 3 patents)
11. Gerd G Kochendoerfer (1 out of 4 patents)
12. Sonya Cressman (1 out of 2 patents)
13. Donald W Low (1 out of 2 patents)
14. Darren Thompson (1 out of 2 patents)
15. Michael A Siani (1 out of 6 patents)
9 patents:
Company Overview
Gryphon Therapeutics, Inc. is a biotechnology company dedicated to developing innovative cancer therapies. Our focus lies in leveraging immuno-oncology and precision medicine to create targeted treatments for patients in need. With a team of experienced scientists and clinicians, we are committed to advancing the field of oncology and improving outcomes for cancer patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gryphon Therapeutics, Inc.. Retrieved from https://idiyas.com/company/gryphon-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]